IPHA News
March 28, 2019
As the campaign begins ahead of the European Parliament elections on May 24th, the Irish Pharmaceutical Healthcare Association (IPHA) has called on candidates to back progress […]
March 7, 2019
New figures show 10 innovative treatments approved by the HSE for use by patients spent 890 days awaiting decisions The 10 new innovative medicines recently approved […]
February 28, 2019
Just one-third of medicines for rare diseases licensed for patients in Europe are available in Ireland, according to new figures released on Rare Disease Day by […]
February 25, 2019
The Irish Pharmaceutical Healthcare Association (IPHA) has defended the industry against a charge of ‘predatory’ pricing by the National Centre for Pharmoeconomics (NCPE). The NCPE is the […]
February 12, 2019
Ever wondered why Facebook is serving you more and more ads for ways to take better care of health or your video feed features patients telling […]
January 30, 2019
The Government has recognised the industry for “very significant work” in planning for Brexit. At the Oireachtas Committee on Health on Wednesday, the Secretary General of […]
January 29, 2019
Lawmakers in Brussels are on track towards weakening the environment for the discovery and adoption of medical innovation, potentially putting at risk the development of new […]
January 18, 2019
There’s a saying in Brussels called going ‘into the tunnel’. It’s when negotiators get together to try to plot a path to resolving Brexit. As the […]
December 27, 2018
Two-thirds of people feel it is ‘unacceptable’ that life-changing medicines are available to patients in other countries before our own can get them, according to a […]